A longer-acting form of Semax, studied for focus, mental clarity, and neuroprotection.
N-Acetyl Semax is a modified form of Semax, the Russian nootropic peptide, researched for the same outcomes—sustained focus, faster mental processing, and steadier mood under cognitive load. The modification protects the peptide from the enzymes that break Semax down, which is what gives each dose a longer working window. The trade-off is evidential: the Russian clinical trials were run on Semax itself, so the outcomes described below come from the parent-compound literature and research-use reports, not from trials of this analogue.
Included because the outcomes researchers look to Semax for—focus, mental clarity, recovery after neurological stress—run through a well-mapped BDNF pathway that this version preserves, while lasting longer per dose. We still score it Experimental: the Russian clinical trials were run on Semax, not on this analogue, and our framework never lets a compound inherit its parent's evidence—the same rule that keeps a blend only as proven as the blend itself. If you want the version with the clinical record, that's Semax. If you want the longer-acting one, this is it, rated honestly.
Built on the same core sequence as Semax, so it engages the same neurotrophic pathway the parent compound is studied for.
Semax-family research centers on BDNF and TrkB neurotrophin signaling—the pathway associated with neuroplasticity, learning, and recovery after neurological stress.
Reported effects on dopamine and serotonin activity are what the attention and mood findings in the parent-compound literature are attributed to.
The added acetyl group resists the enzymes that degrade unmodified Semax, which is what extends the functional window of each dose.
Crosses the blood-brain barrier rapidly, consistent with the parent compound's characterized profile.
WHAT THE RESEARCH MEASURED
Findings describe study outcomes, not expected personal results.
N-Acetyl Semax is investigational and is not approved by the FDA for any use. It has no independent clinical trial record of its own. Sold and offered strictly for laboratory and research use.
